LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that David McGirr, SVP and CFO will present on Thursday, December 6th, at 9:10 A.M. ET at the NASDAQ 20th Annual Investor Conference being held at the Renaissance Chancery Court Hotel in London, England. At the RBC Capital Markets 2007 Healthcare Conference, being held at the Westin Times Square in New York City, Cubist will participate in two panel discussions. On Wednesday, December 12th at 4:30 P.M. ET, David McGirr will participate in a Replacing the Mainstay with Newer and Better Agents panel discussion, and on Thursday, December 13th, at 11:00 A.M. ET, Dr. Barry Eisenstein, Cubist’s SVP, Scientific Affairs, will participate in a New and Powerful Anti-Infectives panel discussion. The presentation and panels will include discussion of the company’s business activities, financial outlook, and current news.
